2 results
Approved WMOCompleted
To demonstrate the additive IOP lowering effect of SIMBRINZA (dosed BID) when added to DUOTRAV solution in subjects with open-angle glaucoma or ocular hypertension.
Approved WMORecruiting
To compare efficacy and cost-effectiveness of early AF ablation by PVI using cryoballoon therapy with standard (medicinal) therapy in patients with heart failure with reduced ejection fraction.